siRNA-based approaches in cancer therapy

Area of Science:

• Genomics
• Molecular Biology
• Pharmacology

Background:

• The human genome sequence enables nucleic acid-based drug discovery.
• Antisense technology shows promise but faces in vivo delivery challenges.
• Post-transcriptional gene silencing (PTGS) using double-stranded RNA (dsRNA) is a natural gene-suppression mechanism.

Purpose of the Study:

• To review advances in PTGS using RNA interference over the last decade.
• To compare PTGS with other oligonucleotide-based approaches.
• To focus on applications of PTGS in oncology.

Main Methods:

• Review of recent literature on PTGS and RNA interference.
• Comparative analysis of different oligonucleotide-based gene silencing strategies.
• Focus on studies relevant to cancer treatment and target validation.

Main Results:

• RNA interference is a rapidly growing field within antigene therapeutics.
• PTGS offers a mechanism for sequence-specific gene silencing.
• Delivery of nucleic acid agents to target RNA remains a key challenge.

Conclusions:

• PTGS via RNA interference presents a powerful tool for gene expression inhibition.
• Significant progress has been made in PTGS technology for therapeutic applications.
• Further research is needed to overcome delivery obstacles for widespread clinical use, particularly in oncology.